Report of the Medicaid Drug Formulary Committee on Drug Use Review
Author: Minnesota. Medicaid Drug Formulary Committee on Drug Use Review
Publisher:
Published: 1992
Total Pages: 14
ISBN-13:
DOWNLOAD EBOOKRead and Download eBook Full
Author: Minnesota. Medicaid Drug Formulary Committee on Drug Use Review
Publisher:
Published: 1992
Total Pages: 14
ISBN-13:
DOWNLOAD EBOOKAuthor: United States. General Accounting Office
Publisher:
Published: 1994
Total Pages: 44
ISBN-13:
DOWNLOAD EBOOKAuthor: Navarro
Publisher: Jones & Bartlett Publishers
Published: 2008-12-11
Total Pages: 659
ISBN-13: 076378883X
DOWNLOAD EBOOKManaged Care Pharmacy Practice, Second Edition offers information critical to the development and operation of a managed care pharmacy program. The text also covers the changes that have taken place within the delivery of pharmacy services, as well as the evolving role of pharmacists.
Author: United States. General Accounting Office
Publisher:
Published: 1989
Total Pages: 16
ISBN-13:
DOWNLOAD EBOOKAuthor: Joint Commission on Prescription Drug Use
Publisher:
Published: 1980
Total Pages: 180
ISBN-13:
DOWNLOAD EBOOKAuthor: Institute of Medicine
Publisher: National Academies Press
Published: 2000-10-03
Total Pages: 280
ISBN-13: 0309183537
DOWNLOAD EBOOKThe VA National Formulary generated controversy, which motivated congressional scrutiny and a directive to the VA to commission this report reviewing the experience with the National Formulary and formulary system. This Institute of Medicine committee was pleased to assist the Congress with this review, in part because the committee saw in the VHA example an opportunity to understand and anticipate problems that all publicly funded programs are likely to encounter in this new age of pharmaceuticals. The Congress asked the committee to review the restrictiveness of the National Formulary, its impact on the costs and quality of care in the VHA, and how it compared to formularies and drug management practices in the private sector and in other public programs, especially Medicaid. Detailed in the pages that follow, the committee's findings and conclusions on these questions are, the committee believes, highly instructive, though not always in the ways that we anticipated.
Author: John D. Bowden
Publisher:
Published: 2009
Total Pages: 32
ISBN-13:
DOWNLOAD EBOOKAuthor: United States. Secretary's Review Committee of the Task Force on Prescription Drugs
Publisher:
Published: 1969
Total Pages: 184
ISBN-13:
DOWNLOAD EBOOKAuthor: Joint Commission on Prescription Drug Use
Publisher:
Published: 1980
Total Pages: 204
ISBN-13:
DOWNLOAD EBOOKAuthor: National Academies of Sciences, Engineering, and Medicine
Publisher: National Academies Press
Published: 2018-03-01
Total Pages: 235
ISBN-13: 0309468086
DOWNLOAD EBOOKThanks to remarkable advances in modern health care attributable to science, engineering, and medicine, it is now possible to cure or manage illnesses that were long deemed untreatable. At the same time, however, the United States is facing the vexing challenge of a seemingly uncontrolled rise in the cost of health care. Total medical expenditures are rapidly approaching 20 percent of the gross domestic product and are crowding out other priorities of national importance. The use of increasingly expensive prescription drugs is a significant part of this problem, making the cost of biopharmaceuticals a serious national concern with broad political implications. Especially with the highly visible and very large price increases for prescription drugs that have occurred in recent years, finding a way to make prescription medicinesâ€"and health care at largeâ€"more affordable for everyone has become a socioeconomic imperative. Affordability is a complex function of factors, including not just the prices of the drugs themselves, but also the details of an individual's insurance coverage and the number of medical conditions that an individual or family confronts. Therefore, any solution to the affordability issue will require considering all of these factors together. The current high and increasing costs of prescription drugsâ€"coupled with the broader trends in overall health care costsâ€"is unsustainable to society as a whole. Making Medicines Affordable examines patient access to affordable and effective therapies, with emphasis on drug pricing, inflation in the cost of drugs, and insurance design. This report explores structural and policy factors influencing drug pricing, drug access programs, the emerging role of comparative effectiveness assessments in payment policies, changing finances of medical practice with regard to drug costs and reimbursement, and measures to prevent drug shortages and foster continued innovation in drug development. It makes recommendations for policy actions that could address drug price trends, improve patient access to affordable and effective treatments, and encourage innovations that address significant needs in health care.